A curated reference for researchers working with synthetic peptide compounds. This hub provides mechanism-of-action overviews, study summaries, and scientific context for every compound in our catalog, drawn from published, peer-reviewed literature.
Synthetic peptides are short chains of amino acids, typically 2–50 residues in length, that mimic or modulate the activity of naturally occurring biological signaling molecules. Their specificity, relative stability compared to full proteins, and tractable synthesis make them valuable tools in laboratory research across a wide range of biological domains.
Research interest in synthetic peptides spans multiple disciplines: cellular biology, endocrinology, metabolic research, wound healing models, and longevity science. The compounds we supply are active areas of published scientific investigation, with peer-reviewed literature available through PubMed, Scopus, and institutional research databases. Explore our GLP-1 research category or review the BPC-157 compound profile for detailed mechanism summaries. Researchers in Texas can find regional supply information on our Houston page.
The summaries below reflect published research findings. They are provided for educational and scientific reference purposes only, and do not constitute medical advice or clinical guidance.
A synthetic pentadecapeptide derived from a sequence found in human gastric juice. BPC-157 has been studied extensively in rodent models for its role in cytoprotective signaling, angiogenesis, and nitric oxide system modulation. Published research examines its interaction with growth hormone receptors and its effects on tendon, ligament, and muscle tissue explants in controlled laboratory settings.
A synthetic analog of Thymosin Beta-4, a naturally occurring 43-amino acid peptide found in high concentrations in blood platelets and wound fluid. Research interest centers on its role in actin sequestration, cell migration, and angiogenesis. TB-500 represents a shorter, more bioavailable fragment of the native protein used in in vitro and animal model studies of tissue repair signaling pathways.
A long-acting glucagon-like peptide-1 (GLP-1) receptor agonist analog. Semaglutide has been the subject of extensive metabolic and endocrine research, with published studies examining its effects on insulin secretion, glucagon suppression, gastric emptying, and appetite regulation in cellular and animal models. Research applications include metabolic disease modeling and GLP-1 receptor pharmacology studies.
A novel dual agonist targeting both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the GLP-1 receptor. Research interest in tirzepatide focuses on the combined incretin effect and its implications for metabolic regulation. Laboratory studies examine receptor binding kinetics, downstream signaling cascades, and comparative pharmacology against single-agonist GLP-1 compounds.
An investigational triple receptor agonist targeting GIP, GLP-1, and glucagon receptors simultaneously. Retatrutide represents a mechanistically distinct approach to metabolic research, with published preclinical data exploring the combined effects of three incretin and counter-regulatory hormone axes. Of significant research interest for understanding energy homeostasis and adipose tissue metabolism.
A synthetic analog of growth hormone-releasing hormone (GHRH) with an extended half-life achieved through Drug Affinity Complex (DAC) technology. Research applications include growth hormone axis pharmacology, pulsatile GH secretion studies, and hypothalamic-pituitary axis modeling. Frequently studied in combination with ghrelin mimetics to examine synergistic secretagogue activity.
A selective growth hormone secretagogue receptor (GHSR) agonist and ghrelin mimetic. Ipamorelin is noted in research for its selectivity, stimulating GH release without significant co-release of cortisol, prolactin, or ACTH at research-relevant concentrations. Published studies examine its dose-response relationship, receptor binding kinetics, and utility as a research tool for isolated GH axis studies.
A stabilized synthetic analog of endogenous GHRH with a trans-3-hexenoic acid modification at the N-terminus. Research applications include hypothalamic-pituitary-somatotroph axis studies, visceral adiposity modeling, and GH pulse amplitude research. The structural modification extends functional half-life compared to native GHRH, making it a useful research tool for sustained axis stimulation studies.
A cyclic heptapeptide melanocortin receptor agonist, specifically targeting MC3R and MC4R. Research interest centers on the central nervous system melanocortin pathway and its role in autonomic nervous system regulation. PT-141 is used as a pharmacological tool compound in receptor binding studies, CNS pathway mapping, and comparative melanocortin pharmacology research.
A naturally occurring tripeptide with high affinity for copper ions. GHK-Cu has been studied extensively in the context of gene expression regulation, wound healing models, and extracellular matrix remodeling. Published research documents its role in modulating over 4,000 human genes in vitro, with particular interest in antioxidant defense, collagen synthesis signaling, and anti-inflammatory pathway research.
A synthetic tetrapeptide (Ala-Glu-Asp-Gly) originally isolated from the pineal gland extract epithalamin. Research interest spans telomere biology, telomerase activation in cell cultures, and circadian rhythm regulation. Published studies from Eastern European research institutions document effects on replicative senescence models, melatonin production in pineal cell cultures, and lifespan parameters in animal models.
Rigorous research requires understanding not just what a compound does, but how to verify what you received, how to store it correctly, and how to interpret the analytical documentation behind it. These guides are written for researchers who want to go deeper than the COA percentage, into the science of verification, handling, and traceability.
Detailed research guides on individual compounds and peptide classes — mechanism of action, published study summaries, in vitro model selection, and research design considerations.
Head-to-head mechanistic comparisons for researchers selecting between related compounds — receptor pharmacology, structural differences, and guidance for matching compound to research question.
Application-focused guides for researchers approaching a specific biological question — longevity, metabolic, recovery, and comparative guides that map compound mechanisms to experimental goals.
The compound profiles above are summaries of existing published scientific literature. All referenced research is available through PubMed (pubmed.ncbi.nlm.nih.gov), Scopus, and institutional journal access. We encourage researchers to consult primary sources directly and to evaluate the methodology and context of each study independently.
Lone Star Peptide Co. does not conduct or sponsor original research. We supply compounds and provide access to existing scientific literature as an educational resource for the research community. No claims made on this page should be interpreted as endorsements of specific research outcomes or therapeutic applications.
For information on how we test and verify every batch we supply, read the Lone Star Research Standards. To understand why this company was founded on a principle of transparency, read Why Lone Star Exists.
Transparent comparisons between Lone Star Peptide Co. and other research peptide suppliers — testing standards, COA transparency, shipping logistics, and what to look for when evaluating any vendor.
⚠ FOR RESEARCH USE ONLY, All information presented on this page is for educational and scientific reference purposes. Lone Star Peptide Co. compounds are intended exclusively for in vitro and laboratory research. These compounds are not approved by the FDA for human consumption or therapeutic use. Nothing on this page constitutes medical advice, clinical guidance, or endorsement of human use. Researchers are responsible for obtaining appropriate institutional and regulatory approvals prior to use.
Source Research Compounds
Lone Star Peptide Co. supplies all compounds referenced in this research library. Every batch is independently tested by Freedom Diagnostics — HPLC purity, LC-MS identity confirmation, and endotoxin screening. Batch-specific COAs published by lot number. Houston-based, same-day dispatch before 3 PM CST.